Search Results for
January 13, 2022 | Democracy Journal
Americans were more divided than ever in 2021, but everyone in the country still agreed on one thing: The Democratic Party has a messaging problem.
“We’ve got a national branding problem that is probably deeper than a lot of people suspect,” Democratic pollster Brian Stryker, who is currently working with the centrist think tank Third Way to understand why Democrats lost the recent governors’ race in Virginia told The New York Times. “I’m not going to argue it’s working right now, but I need it to work when it matters,” Rep. Sean Patrick Maloney (D-NY), chair of the Democratic Congressional Campaign Committee told The Washington Post in November of the Democrats’ efforts to sell their legislative victories. Senator Kirsten Gillibrand (D-NY) seemingly agrees, telling attendees at a recent fundraising dinner that “Democrats are terrible at messaging. It’s just a fact.”
December 22, 2021 | Common Dreams
The Covid-19 threat will not simply go away—especially when addressed with half measures. The administration must use its authority under the Defense Production Act much more wisely and aggressively.
December 13, 2021 | The American Prospect
We are rapidly approaching the one-year anniversary of January 6, and Attorney General Merrick Garland has yet to give any sign that his Justice Department is independently investigating former President Trump and his fellow instigators. This is, by far, Garland’s most high-profile failure when it comes to accountability for the prior administration, one that more observers have begun to notice. But it is not the only one.
December 08, 2021 | Talking Points Memo
Progressives, prison workers and prisoners are in agreement: the Director of the Federal Bureau of Prisons, Michael Carvajal, should be fired. The Bureau of Prisons is in a crisis several layers deep, and new leadership will be key to its reformation.
November 18, 2021 | The American Prospect
The Biden administration inherited a morass of understaffed and undermined federal agencies, weakened by the Trump administration. It makes sense that building back the government’s capacity would be an uphill battle for the Biden administration, with so many years of policymaking undermined by his predecessor. What doesn’t make sense is the jarring number of cases in which the administration is going out of its way, at considerable cost, to uphold Trump-era policies that go against Biden’s stated agenda and the public interest.
November 05, 2021 | The American Prospect
With his legislative climate agenda hanging in the balance, President Biden turned to executive action this week in his attempt to “assert American leadership” at COP26 in Glasgow. On Tuesday, the Environmental Protection Agency (EPA) announced sweeping new rules to curb methane emissions. Those standards, which the agency estimates would eliminate a greater volume of emissions between 2023 and 2035 than those emitted from all U.S. passenger cars and commercial planes in 2019, were rightly applauded. For now, however, these are just estimates. Ensuring that they turn into real-life emissions reductions that meet or exceed expectations will require that agencies have the capacity to promptly write strong new rules and, then, enforce them.
October 29, 2021 | The American Prospect
Dr. Robert Califf appears to be the clearest front-runner for the (somehow) still open position of commissioner of the Food and Drug Administration. After floating his name in the press a few weeks ago, President Biden recently met with Califf in private. Such meetings tend to be the final step before a nominee is announced.
There’s just one problem: Califf is a longtime political consultant to Big Pharma and, more recently, to Big Tech. In fact, he’s so tied to those industries that he once earned the ire of a certain crucial senator from West Virginia.
October 20, 2021 | The American Prospect
It was never a secret that Attorney General Merrick Garland was among the key Biden administration figures opposing Jonathan Kanter’s nomination as assistant attorney general for antitrust. Ultimately, however, Garland did not get his way; the appointment went to Kanter rather than to one of the many Big Tech–allied BigLaw partners whom Garland favored. In view of Kanter’s career as a plaintiff’s lawyer, his nomination was rightly celebrated as a decisive victory by antitrust reformers and BigLaw opponents alike. But it was just one battle in a broader war for renewed anti-monopoly enforcement and a DOJ eager to build back better in every policy area.
October 15, 2021 | Talking Points Memo
Facebook continues to lie to the public with abandon. That is one of the main takeaways from the Facebook whistleblower’s testimony last week. Even now, having been called out, Facebook is frantically working to obscure and underplay its own dishonesty.
October 08, 2021
President Biden has failed to live up to his promise to progressives to be a climate president. U.S. emissions continue to rise. Last week, 23 unique plant and animal species were declared extinct. A catastrophic pipeline oil spill in California is actively killing fish, birds, and wetland ecosystems. And in violation of treaty rights that are constitutionally the supreme law of the land, Biden allowed Enbridge’s Line 3 tar sands pipeline to become operational on October 1, which will add emissions equivalent to 50 new coal-fired power plants and will inevitably spill. Biden is standing in support while water protectors are violently arrested and the Anishinaabe peoples living in the path of the project are terrorized and abused.
September 29, 2021 | The American Prospect
When United States Trade Representative Katherine Tai announced this past May that the U.S. would support the TRIPS waiver on COVID-19 vaccines at the World Trade Organization (WTO), we at the Revolving Door Project celebrated the administration’s decision as “a transformative, hopeful event.” The waiver proposal calls on the WTO’s Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council to suspend intellectual-property protections on COVID-19 therapeutics, diagnostics, and vaccines to ensure materials necessary for combating the pandemic are “available promptly, in sufficient quantities and at affordable price to meet global demand.”
September 23, 2021
In his time on D.C.’s Public Service Commission and before that as a corporate lawyer, Phillips consistently sided with utilities over the public interest.
September 07, 2021 | American Prospect
Apparently, Harris just doesn’t get why regulators have to be so skeptical of the industry all the time—which makes sense, coming from a fintech executive who’s advocated for the industry on both sides of the revolving door.